Workshop Organization |
ORGANIZING COMMITTEE
|
Douglas Richman, Chair
VA San Diego Healthcare System and
University of California San Diego, USA
|
Brendan Larder, Co-Chair
RDI, UK |
Charles Boucher
Erasmus Medical Center Rotterdam and
University Hospital Utrecht, the Netherlands |
John Mellors
University of Pittsburgh, USA |
| |
|
| |
SCIENTIFIC COMMITTEE
|
|
Lee Bacheler
VircoLab, Inc
|
Kurt Hertogs
Tibotec bvba |
Barry Bernstein
Abbott Laboratories
|
Rolf Kaiser
University of Cologne |
Nick Cammack
Roche Palo Alto
|
Daniel Kuritzkes
Brigham and Women's Hospital |
François Clavel
Inserm U552
|
Susan Little
University of California, San Diego |
Bonaventura Clotet
Fundacio IRSI Caixa
|
Doug Mayers
Idenix Pharmaceuticals |
John Coffin
National Cancer Institute-Frederick
|
Michael Miller
Gilead Sciences |
Abel De La Rosa
Pharmasset
|
Carlo Perno
Universita Di Tor Vergata |
Steven Deeks
University of California, San Francisco
|
Christos Petropoulos
Monogram Biosciences |
Matthias Götte
McGill University
|
Deenan Pillay
University College London |
Robert Grant
Gladstone/UCSF
|
Lisa Ross
GlaxoSmithKline |
Huldrych Günthard
University Hospital Zurich
|
Jonathan
Schapiro
National Hemophilia Center - Israel |
David Hall
Boehringer Ingelheim Pharmaceuticals
|
Celia
Schiffer
University of Massachusetts Medical School |
George Hanna
Bristol-Myers Squibb
|
Raymond Schinazi
Emory University/VA Medical Center |
Richard Harrigan
BC Centre for Excellence in HIV/AIDS
|
Mark Wainberg
McGill University AIDS Centre |
Daria Hazuda
Merck Research Labs
|
Mike Westby
Pfizer Global R&D |
Walid Heneine
Centers for Disease Control and Prevention |
Andrew Zolopa
Stanford University
|
|
